One Gene is an authoritative cancer genetic testing organization, using advanced genetic testing technology and genetic big data computing technology to provide the public with genetic testing services for early cancer screening, early prevention and precise treatment guidance. Recently announced the completion of the B-round financing of tens of millions of RMB, which was invested by the listed company Chengda Pharmaceutical. This round of funds will be mainly used for the registration and application of colon cancer early screening products and the research and development of gastric cancer early screening and liver cancer early screening. One Gene focuses on the early screening track of non-invasive cancer in the digestive tract.
This article is transferred from: https://www.itjuzi.com/investevent/13707092
This site is only for collection, and the copyright belongs to the original author.